Total Valuation
Nexien BioPharma has a market cap or net worth of $7.08K. The enterprise value is $374.17K.
Market Cap$7.08K
Enterprise Value$374.17K
Share Statistics
Nexien BioPharma has 70,772,194 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding70,772,194
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nexien BioPharma’s return on equity (ROE) is 0.66 and return on invested capital (ROIC) is 318.40%.
Return on Equity (ROE)0.66
Return on Assets (ROA)-57.14
Return on Invested Capital (ROIC)318.40%
Return on Capital Employed (ROCE)0.43
Revenue Per Employee0.00
Profits Per Employee-23.91K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nexien BioPharma is ―. Nexien BioPharma’s PEG ratio is 0.13.
PE Ratio―
PS Ratio0.00
PB Ratio-3.22
Price to Fair Value-3.22
Price to FCF-18.10
Price to Operating Cash Flow-0.10
PEG Ratio0.13
Income Statement
In the last 12 months, Nexien BioPharma had revenue of 0.00 and earned -239.00K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-156.00K
Pretax Income-239.00K
Net Income-239.00K
EBITDA-337.00
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -61.78K and capital expenditures 1.00, giving a free cash flow of -61.78K billion.
Operating Cash Flow-61.78K
Free Cash Flow-61.78K
Free Cash Flow per Share>-0.01
Dividends & Yields
Nexien BioPharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.96
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)47.23
Average Volume (3m)1.81K
Important Dates
Nexien BioPharma upcoming earnings date is Nov 14, 2018, TBA (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateNov 14, 2018
Ex-Dividend Date―
Financial Position
Nexien BioPharma as a current ratio of 0.01, with Debt / Equity ratio of -86.44%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap0.27
Net Debt to EBITDA-914.16
Interest Coverage Ratio-1.87
Taxes
In the past 12 months, Nexien BioPharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nexien BioPharma EV to EBITDA ratio is -4.37K, with an EV/FCF ratio of -22.89.
EV to Sales0.00
EV to EBITDA-4.37K
EV to Free Cash Flow-22.89
EV to Operating Cash Flow-22.89
Balance Sheet
Nexien BioPharma has $8.29K in cash and marketable securities with $375.38K in debt, giving a net cash position of -$367.09K billion.
Cash & Marketable Securities$8.29K
Total Debt$375.38K
Net Cash-$367.09K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nexien BioPharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―